Search
for
Sort by
Research 811–840 of 1000+
- Three-dimensional ultrastructural analysis of human skin with the arrector pili muscle interacting with the hair follicle epithelium
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Histopathological Evaluation of Human Placental Extract as a Direct Pulp-Capping Material in Dogs' Teeth
- Dermatophytosis in Clinically Infected Cats: Diagnoses and Efficacy Therapy
- Treatments for alopecia areata: a network meta-analysis
- A guide to cost-effective emollient prescribing
- Scaffolds for epithelial and hair follicle regeneration
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- 854 CCL5 affects the hair-inductive capacity of three-dimensional (3D)-cultured dermal papilla cells
- New-onset systemic lupus erythematosus during pregnancy: A challenge in diagnosis
- Biomaterials for dermal substitutes
- Plaque psoriasis
- Hair growth promoting effect of essence manufactured with products fermented by Lactobacillus rhamnosus and Backryeoncho (Opuntia ficus-indica var. sarboten) fruits in mice
- Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs
- Hair Disorders
- Primary cicatricial alopecias
- JCAS gets indexed in PubMed
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Cultural evolution as a possible triggering or causative factor of common baldness
- Hair loss
- Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria
- Management of androgenetic alopecia
- Investigating drug induced alopecia
- Evaluation method of the degree of hair damage. (I). Measurement of tensile strength of human hair by "the multi-point tension test method".
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Unveiling the Connection between Gut Microbiome and Polycystic Ovary Syndrome (PCOS)
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Case report: Successful treatment of a thallium sulfate intoxication in a dog with use of Prussian blue